Cancer Biology & Therapy

Papers
(The H4-Index of Cancer Biology & Therapy is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Target c-Myc to treat pancreatic cancer67
Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis38
Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism33
Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer32
HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway31
Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma29
CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation28
Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo24
LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis24
Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status23
Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy23
The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy23
CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA22
NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation22
Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines22
Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma22
The role of CD133 in hepatocellular carcinoma21
Heparan sulfate proteoglycans as targets for cancer therapy: a review21
The human microbiome and cancer: a diagnostic and therapeutic perspective20
Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease19
0.058980226516724